ES8105783A1 - Un procedimiento para preparar un lipopolisacarido - Google Patents

Un procedimiento para preparar un lipopolisacarido

Info

Publication number
ES8105783A1
ES8105783A1 ES493061A ES493061A ES8105783A1 ES 8105783 A1 ES8105783 A1 ES 8105783A1 ES 493061 A ES493061 A ES 493061A ES 493061 A ES493061 A ES 493061A ES 8105783 A1 ES8105783 A1 ES 8105783A1
Authority
ES
Spain
Prior art keywords
lipopolysaccharide
tumors
active component
immunotherapeutic agent
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES493061A
Other languages
English (en)
Spanish (es)
Other versions
ES493061A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of ES493061A0 publication Critical patent/ES493061A0/es
Publication of ES8105783A1 publication Critical patent/ES8105783A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES493061A 1979-07-04 1980-07-03 Un procedimiento para preparar un lipopolisacarido Expired ES8105783A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8468179A JPS568320A (en) 1979-07-04 1979-07-04 Drug for tumor immunotherapy comprising lipopolysaccharide as active constituent

Publications (2)

Publication Number Publication Date
ES493061A0 ES493061A0 (es) 1981-06-16
ES8105783A1 true ES8105783A1 (es) 1981-06-16

Family

ID=13837428

Family Applications (1)

Application Number Title Priority Date Filing Date
ES493061A Expired ES8105783A1 (es) 1979-07-04 1980-07-03 Un procedimiento para preparar un lipopolisacarido

Country Status (8)

Country Link
US (2) US4329452A (cg-RX-API-DMAC7.html)
JP (1) JPS568320A (cg-RX-API-DMAC7.html)
CA (1) CA1132047A (cg-RX-API-DMAC7.html)
CH (1) CH650799A5 (cg-RX-API-DMAC7.html)
ES (1) ES8105783A1 (cg-RX-API-DMAC7.html)
FR (1) FR2484258A1 (cg-RX-API-DMAC7.html)
IT (1) IT1132168B (cg-RX-API-DMAC7.html)
SU (1) SU1232124A3 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5718619A (en) * 1980-07-10 1982-01-30 Chisato Maruyama Tumor immunotherapy agent containing lipopolysaccharide as active principle
JPS59161320A (ja) * 1983-03-04 1984-09-12 Maruyama Chisato リポ多糖体およびその製造法
US4612304A (en) * 1985-06-11 1986-09-16 Ss Pharmaceutical Co., Ltd. Antitumor formulation containing lipopolysaccharide with trehalose derivatives
US4818751A (en) * 1985-07-02 1989-04-04 Zeria Shinyaku Kogyo Kabushiki Kaisha Cosmetics
EP0295749A1 (en) * 1987-06-15 1988-12-21 Duphar International Research B.V Sulpholipopolysaccharides as stimulators of the non-specific defence mechanism
US4798369A (en) * 1987-11-03 1989-01-17 The Firestone Tire & Rubber Company Ultrasonic air spring system
US7063844B2 (en) 1992-12-10 2006-06-20 The Brigham And Women's Hospital, Inc. Presentation of hydrophobic antigens to T-cells by CD1 molecules
US5853737A (en) * 1992-12-10 1998-12-29 Brigham And Women's Hospital Method for inducing a CD1-restricted immune response
US6238676B1 (en) * 1992-12-10 2001-05-29 Brigham And Women's Hospital Presentation of hydrophobic antigens to T-cells by CD1 molecules
US5712123A (en) * 1994-10-07 1998-01-27 Board Of Trustees Of The University Of Illinois Mixture having antitumor activities
CA2293821C (en) * 1997-06-10 2004-05-11 Tai Ho Chung Carbohydrate complex extracted from mycobacterium tuberculosis and process for the preparation thereof
US5869645A (en) * 1997-10-15 1999-02-09 Board Of Trustees Of The University Of Illinois Method for isolating high molecular weight antineoplastic glycans using urea
NZ505538A (en) * 2000-07-03 2004-12-24 Malaghan Inst Of Medical Res A vaccine comprising immunogenic acyl glyceryl phosphatidylinositol manno-oligosaccharide (PIM); and the use of PIM for inducing an immune response in a patient effective in the prevention or treatment of Th2-mediated diseases or disorders such as asthma
US8034359B2 (en) 2004-06-07 2011-10-11 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to cancers
US9107864B2 (en) 2004-06-07 2015-08-18 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
DK1765391T3 (da) * 2004-06-07 2013-03-25 Qu Biolog Inc Bakterielle præparater til behandlingen af cancer
US8501198B2 (en) 2004-06-07 2013-08-06 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
US20070161546A1 (en) * 2005-12-15 2007-07-12 Colm King Methods and compositions for treatment of cancer
US8980279B2 (en) 2010-07-26 2015-03-17 Qu Biologics Personalized site-specific immunomodulation
JP2015157763A (ja) * 2012-05-28 2015-09-03 エヌエーアイ株式会社 認知症の治療剤及び予防剤
WO2015153470A1 (en) 2014-03-31 2015-10-08 University Of Utah Research Foundation Fluid analysis device and associated systems and methods
CN113855791B (zh) 2014-05-02 2024-11-19 Qu生物制药公司 抗微生物免疫调节
WO2022075458A1 (ja) * 2020-10-09 2022-04-14 ゼリア新薬工業株式会社 結核菌抽出物の新規用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1188519A (en) * 1966-10-27 1970-04-15 Wellcome Found Method for the Purification of Lipopolysaccharides
FR2227862A1 (en) * 1973-05-04 1974-11-29 Anvar Non-arthrogenic immunological adjuvants - obtained by extraction of lipid-free mycobacterial residues
NL7308450A (cg-RX-API-DMAC7.html) * 1972-06-20 1973-12-27
DE2527636A1 (de) * 1974-06-20 1976-01-08 Anvar Verfahren zur herstellung von mycobakteriellen fraktionen

Also Published As

Publication number Publication date
US4394502A (en) 1983-07-19
CA1132047A (en) 1982-09-21
FR2484258B1 (cg-RX-API-DMAC7.html) 1984-11-30
JPS568320A (en) 1981-01-28
ES493061A0 (es) 1981-06-16
CH650799A5 (de) 1985-08-15
IT1132168B (it) 1986-06-25
JPS6256843B2 (cg-RX-API-DMAC7.html) 1987-11-27
SU1232124A3 (ru) 1986-05-15
FR2484258A1 (fr) 1981-12-18
US4329452A (en) 1982-05-11
IT8023219A0 (it) 1980-07-03

Similar Documents

Publication Publication Date Title
ES8105783A1 (es) Un procedimiento para preparar un lipopolisacarido
IE44749L (en) Cyclopeptide
ES475240A1 (es) Un procedimiento de compuestos polienicos.
IT8125678A0 (it) Macchina elettrica, specialmente per dispositivi di avviamento dimotori endotermici.
MX170804B (es) Procedimiento mejorado para la hidrogenolisis/deshidrohalogenacion de fluorohalocarburos o fluorohalohidrocarburos
UA5972A1 (uk) Спосіб отримання заміщених 2-меркапто-імідазолів
ES522356A0 (es) Un procedimiento mejorado para preparar peroxido de hidrogeno.
AU518476B2 (en) Box spring, assembly
EP0014958A3 (de) Verfahren zur Herstellung von 4,5-Perfluor-1,3-dioxolanen
ES295796Y (es) Conjunto de muelles para tapiceria.
IT7821657A0 (it) Procedimento per fabbricare epossidi partendo da alcan-dioli-1,2.
AU2877877A (en) 2 Disubstituted 1, 3-benzodioxan 4-on-2-yl-derivatives
ES458485A1 (es) Procedimiento para preparar polifenilfosfonatos aromaticos.
JPS52153947A (en) Dicyclododecyl peroxycarbonate
ES8202545A1 (es) Metodo perfeccionado para la fabricacion de 4-tiazolidonas,2-substituidas
JPS549273A (en) 7-arginylamono-4-methylcoumarin
SU637075A3 (ru) Способ получени 2,5-дихлор-п-ксилола
JPS5430135A (en) 4-hydroxy-4-methyl-cyclohexene-2-one-1
JPS5273878A (en) Synthesis of 6-carboxyacetyl-3,4-dihydrocarbostyril
IT7924113A0 (it) Procedimento per produrre eteri bis (n,n-dialchilammino) alchilici.
JPS53108974A (en) 7-arginylamino-4-methylcoumarin
ES465216A1 (es) Un procedimiento para la preparacion de d-homoesteroides.
SU617124A1 (ru) Способ получени деталей с отверсти ми из листового металла
JPS5223086A (en) Novel method of preparing 2,3- dioxopiperazine
JPS5392774A (en) 5,6,7,3',4',5'-hexahydrooxyflavone